# BEONE MEDICINES LTD. (ONC) FY2026 Q1 P&L / Income Statement

- Company: BEONE MEDICINES LTD. (ONC)
- Period: 2026-01-01 to 2026-03-31
- Filing: Q1 FY2026 10-Q, filed 2026-05-06, accession number 0001628280-26-030867
- Page: https://plicit.ai/financials/onc/fy2026-q1-income-statement
- Chart image: https://plicit.ai/charts/onc-fy2026-q1-income-statement-sankey.png

## Chart details: Revenue by Product and Service by Geography

Income statement for 2026-01-01 through 2026-03-31. View: Product and Service by Geographical. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

- **Total revenues**: 1,513,438,000 US dollars
- **Cost of revenue (calculated)**: 167,215,000 US dollars
- **Gross profit**: 1,346,223,000 US dollars
- **Operating expenses (calculated)**: 1,096,321,000 US dollars
- **Income from operations**: 249,902,000 US dollars
- **Other income (expense), net (calculated)**: 9,313,000 US dollars
- **Income before income taxes**: 259,215,000 US dollars
- **Income tax expense**: 31,858,000 US dollars
- **Net income**: 227,357,000 US dollars
- **Other revenue - CHINA**: 6,792,000 US dollars
- **Other revenue - UNITED STATES**: 16,642,000 US dollars
- **Other revenue - Europe - total revenue**: 2,675,000 US dollars
- **Product revenue, net - Rest of world - total revenue**: 65,213,000 US dollars
- **Product revenue, net - CHINA**: 465,182,000 US dollars
- **Product revenue, net - UNITED STATES**: 765,613,000 US dollars
- **Product revenue, net - Europe - total revenue**: 191,321,000 US dollars
- **Cost of sales - product**: 167,215,000 US dollars
- **Selling, general and administrative**: 555,097,000 US dollars
- **Research and development**: 541,224,000 US dollars

### Chart connections

- Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
- Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.

## Chart details: Revenue by Geography

- Page: https://plicit.ai/financials/onc/fy2026-q1-income-statement/revenue-by-geography
- Chart image: https://plicit.ai/charts/onc-fy2026-q1-revenue-by-geography-sankey.png

Income statement for 2026-01-01 through 2026-03-31. View: Geography. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

- **Total revenues**: 1,513,438,000 US dollars
- **Cost of revenue (calculated)**: 167,215,000 US dollars
- **Gross profit**: 1,346,223,000 US dollars
- **Operating expenses (calculated)**: 1,096,321,000 US dollars
- **Income from operations**: 249,902,000 US dollars
- **Other income (expense), net (calculated)**: 9,313,000 US dollars
- **Income before income taxes**: 259,215,000 US dollars
- **Income tax expense**: 31,858,000 US dollars
- **Net income**: 227,357,000 US dollars
- **UNITED STATES**: 782,255,000 US dollars
- **CHINA**: 471,974,000 US dollars
- **Europe - total revenue**: 193,996,000 US dollars
- **Rest of world - total revenue**: 65,213,000 US dollars
- **Cost of sales - product**: 167,215,000 US dollars
- **Selling, general and administrative**: 555,097,000 US dollars
- **Research and development**: 541,224,000 US dollars

### Chart connections

- Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
- Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.

## Chart details: Revenue by Product and Service

- Page: https://plicit.ai/financials/onc/fy2026-q1-income-statement/revenue-by-product-and-service
- Chart image: https://plicit.ai/charts/onc-fy2026-q1-revenue-by-product-and-service-sankey.png

Income statement for 2026-01-01 through 2026-03-31. View: Product and service. Revenue and costs use their disclosed categories.

- **Total revenues**: 1,513,438,000 US dollars
- **Cost of revenue (calculated)**: 167,215,000 US dollars
- **Gross profit**: 1,346,223,000 US dollars
- **Operating expenses (calculated)**: 1,096,321,000 US dollars
- **Income from operations**: 249,902,000 US dollars
- **Other income (expense), net (calculated)**: 9,313,000 US dollars
- **Income before income taxes**: 259,215,000 US dollars
- **Income tax expense**: 31,858,000 US dollars
- **Net income**: 227,357,000 US dollars
- **Product revenue, net revenue**: 1,487,329,000 US dollars
- **Other revenue**: 26,109,000 US dollars
- **Product revenue, net cost of revenue**: 167,215,000 US dollars
- **Selling, general and administrative**: 555,097,000 US dollars
- **Research and development**: 541,224,000 US dollars

### Chart connections

- Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
- Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.

## Chart details: Revenue by Product Name by Product and Service

- Page: https://plicit.ai/financials/onc/fy2026-q1-income-statement/revenue-by-product-name-by-product-and-service
- Chart image: https://plicit.ai/charts/onc-fy2026-q1-revenue-by-product-name-by-product-and-service-sankey.png

Income statement for 2026-01-01 through 2026-03-31. View: Product Name by Product and Service. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

- **Total revenues**: 1,513,438,000 US dollars
- **Cost of revenue (calculated)**: 167,215,000 US dollars
- **Gross profit**: 1,346,223,000 US dollars
- **Operating expenses (calculated)**: 1,096,321,000 US dollars
- **Income from operations**: 249,902,000 US dollars
- **Other income (expense), net (calculated)**: 9,313,000 US dollars
- **Income before income taxes**: 259,215,000 US dollars
- **Income tax expense**: 31,858,000 US dollars
- **Net income**: 227,357,000 US dollars
- **BLINCYTO - Product revenue, net**: 34,035,000 US dollars
- **BRUKINSA - Product revenue, net**: 1,094,843,000 US dollars
- **KYPROLIS - Product revenue, net**: 16,971,000 US dollars
- **Other - Product revenue, net**: 33,192,000 US dollars
- **POBEVCY - Product revenue, net**: 12,127,000 US dollars
- **TEVIMBRA - Product revenue, net**: 206,241,000 US dollars
- **XGEVA - Product revenue, net**: 89,920,000 US dollars
- **Undisclosed (calculated)**: 26,109,000 US dollars
- **Cost of sales - product**: 167,215,000 US dollars
- **Selling, general and administrative**: 555,097,000 US dollars
- **Research and development**: 541,224,000 US dollars

### Chart connections

- Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
- Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.
